-
1
-
-
0032809977
-
Initial paclitaxel improves outcome compared with cmfp combination chemotherapy as front-line therapy in untreated metastatic breast cancer
-
Bishop JF, Dewar J, Toner GC, Smith J, Tattersall MH, Olver IN, et al. Initial paclitaxel improves outcome compared with cmfp combination chemotherapy as front-line therapy in untreated metastatic breast cancer. J Clin Oncol 1999;17:2355-64.
-
(1999)
J Clin Oncol
, vol.17
, pp. 2355-2364
-
-
Bishop, J.F.1
Dewar, J.2
Toner, G.C.3
Smith, J.4
Tattersall, M.H.5
Olver, I.N.6
-
2
-
-
0032751112
-
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer
-
Buzdar AU, Singletary SE, Theriault RL, Booser DJ, Valero V, Ibrahim N, et al. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. J Clin Oncol 1999;17:3412-7.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3412-3417
-
-
Buzdar, A.U.1
Singletary, S.E.2
Theriault, R.L.3
Booser, D.J.4
Valero, V.5
Ibrahim, N.6
-
3
-
-
33645736326
-
Peripheral neuropathy induced by microtubulestabilizing agents
-
Lee JJ, Swain SM. Peripheral neuropathy induced by microtubulestabilizing agents. J Clin Oncol 2006;24:1633-42.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1633-1642
-
-
Lee, J.J.1
Swain, S.M.2
-
5
-
-
79251514958
-
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
-
Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuentes D, et al. Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 2011;125:767-74.
-
(2011)
Breast Cancer Res Treat
, vol.125
, pp. 767-774
-
-
Hershman, D.L.1
Weimer, L.H.2
Wang, A.3
Kranwinkel, G.4
Brafman, L.5
Fuentes, D.6
-
6
-
-
84869435971
-
Six cycles of doxorubicin and cyclophosphamide or paclitaxel are not superior to 4 cycles as adjuvant chemotherapy for breast cancer in women with 0-3 positive axillary nodes: Calgb 40101
-
Jul 23. [Epub ahead of print]
-
Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan RO, et al. Six cycles of doxorubicin and cyclophosphamide or paclitaxel are not superior to 4 cycles as adjuvant chemotherapy for breast cancer in women with 0-3 positive axillary nodes: Calgb 40101. J Clin Oncol. 2012 Jul 23. [Epub ahead of print].
-
(2012)
J Clin Oncol
-
-
Shulman, L.N.1
Cirrincione, C.T.2
Berry, D.A.3
Becker, H.P.4
Perez, E.A.5
O'Regan, R.O.6
-
7
-
-
34548292504
-
Plink: A tool set for whole-genome association and population-based linkage analyses
-
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. Plink: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81: 559 - 75.
-
(2007)
Am J Hum Genet
, vol.81
, pp. 559-575
-
-
Purcell, S.1
Neale, B.2
Todd-Brown, K.3
Thomas, L.4
Ferreira, M.A.5
Bender, D.6
-
8
-
-
77952574876
-
Quality control for genome-wide association studies
-
Weale ME. Quality control for genome-wide association studies. Methods Mol Biol 2010;628:341- 72.
-
(2010)
Methods Mol Biol
, vol.628
, pp. 341-372
-
-
Weale, M.E.1
-
9
-
-
33746512512
-
Principal components analysis corrects for stratification in genomewide association studies
-
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 2006;38:904-9.
-
(2006)
Nat Genet
, vol.38
, pp. 904-909
-
-
Price, A.L.1
Patterson, N.J.2
Plenge, R.M.3
Weinblatt, M.E.4
Shadick, N.A.5
Reich, D.6
-
10
-
-
35348983887
-
A second generation human haplotype map of over 3.1 million snps
-
Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al.A second generation human haplotype map of over 3.1 million snps. Nature 2007;449:851-61.
-
(2007)
Nature
, vol.449
, pp. 851-861
-
-
Frazer, K.A.1
Ballinger, D.G.2
Cox, D.R.3
Hinds, D.A.4
Stuve, L.L.5
Gibbs, R.A.6
-
11
-
-
78649508578
-
Mach: Using sequence and genotype data to estimate haplotypes and unobserved genotypes
-
Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. Mach: Using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-34.
-
(2010)
Genet Epidemiol
, vol.34
, pp. 816-834
-
-
Li, Y.1
Willer, C.J.2
Ding, J.3
Scheet, P.4
Abecasis, G.R.5
-
12
-
-
0000336139
-
Regression models and life tables
-
Cox DR. Regression models and life tables. J Royal Stat Soc Series B 1972;34:187- 220.
-
(1972)
J Royal Stat Soc Series B
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
17
-
-
33644974019
-
A fast and flexible statistical model for largescale population genotype data: Applications to inferring missing genotypes and haplotypic phase
-
Scheet P, Stephens M. A fast and flexible statistical model for largescale population genotype data: Applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006;78:629-44.
-
(2006)
Am J Hum Genet
, vol.78
, pp. 629-644
-
-
Scheet, P.1
Stephens, M.2
-
18
-
-
18444369013
-
The structure of haplotype blocks in the human genome
-
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
-
(2002)
Science
, vol.296
, pp. 2225-2229
-
-
Gabriel, S.B.1
Schaffner, S.F.2
Nguyen, H.3
Moore, J.M.4
Roy, J.5
Blumenstiel, B.6
-
19
-
-
77957935114
-
Ephrin-a5 and epha5 interaction induces synaptogenesis during early hippocampal development
-
Akaneya Y, Sohya K, Kitamura A, Kimura F, Washburn C, Zhou R, et al. Ephrin-a5 and epha5 interaction induces synaptogenesis during early hippocampal development. PLoS One 2010;5:e12486.
-
(2010)
PLoS One
, vol.5
-
-
Akaneya, Y.1
Sohya, K.2
Kitamura, A.3
Kimura, F.4
Washburn, C.5
Zhou, R.6
-
20
-
-
77957237015
-
Transcriptional profiling of the injured sciatic nerve of mice carrying the wld(s) mutant gene: Identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration
-
Barrette B, Calvo E, Vallieres N, Lacroix S. Transcriptional profiling of the injured sciatic nerve of mice carrying the wld(s) mutant gene: Identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration. Brain Behav Immun 2010;24:1254-67.
-
(2010)
Brain Behav Immun
, vol.24
, pp. 1254-1267
-
-
Barrette, B.1
Calvo, E.2
Vallieres, N.3
Lacroix, S.4
-
21
-
-
34347240987
-
Mutations in fgd4 encoding the rho gdp/gtp exchange factor frabin cause autosomal recessive charcot-marie-tooth type 4h
-
Delague V, Jacquier A, Hamadouche T, Poitelon Y, Baudot C, Boccaccio I, et al. Mutations in fgd4 encoding the rho gdp/gtp exchange factor frabin cause autosomal recessive charcot-marie-tooth type 4h. Am J Hum Genet 2007;81:1-16.
-
(2007)
Am J Hum Genet
, vol.81
, pp. 1-16
-
-
Delague, V.1
Jacquier, A.2
Hamadouche, T.3
Poitelon, Y.4
Baudot, C.5
Boccaccio, I.6
-
22
-
-
34347213793
-
Peripheral nerve demyelination caused by a mutant rho gtpase guanine nucleotide exchange factor, frabin/fgd4
-
Stendel C, Roos A, Deconinck T, Pereira J, Castagner F, Niemann A, et al. Peripheral nerve demyelination caused by a mutant rho gtpase guanine nucleotide exchange factor, frabin/fgd4. Am J Hum Genet 2007;81:158- 64.
-
(2007)
Am J Hum Genet
, vol.81
, pp. 158-164
-
-
Stendel, C.1
Roos, A.2
Deconinck, T.3
Pereira, J.4
Castagner, F.5
Niemann, A.6
-
23
-
-
65249157015
-
Further evidence that mutations in fgd4/frabin cause charcot-marie- Tooth disease type 4h
-
Fabrizi GM, Taioli F, Cavallaro T, Ferrari S, Bertolasi L, Casarotto M, et al. Further evidence that mutations in fgd4/frabin cause charcot-marie- tooth disease type 4h. Neurology 2009;72:1160-4.
-
(2009)
Neurology
, vol.72
, pp. 1160-1164
-
-
Fabrizi, G.M.1
Taioli, F.2
Cavallaro, T.3
Ferrari, S.4
Bertolasi, L.5
Casarotto, M.6
-
24
-
-
61849087866
-
A novel frabin (fgd4) nonsense mutation p.R275x associated with phenotypic variability in cmt4h
-
Houlden H, Hammans S, Kati fi H, Reilly MM. A novel frabin (fgd4) nonsense mutation p.R275x associated with phenotypic variability in cmt4h. Neurology 2009;72:617-20.
-
(2009)
Neurology
, vol.72
, pp. 617-620
-
-
Houlden, H.1
Hammans, S.2
Katifi, H.3
Reilly, M.M.4
-
26
-
-
0024556011
-
Taxol produces a predominantly sensory neuropathy
-
Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, et al. Taxol produces a predominantly sensory neuropathy. Neurology 1989;39:368-73.
-
(1989)
Neurology
, vol.39
, pp. 368-373
-
-
Lipton, R.B.1
Apfel, S.C.2
Dutcher, J.P.3
Rosenberg, R.4
Kaplan, J.5
Berger, A.6
-
27
-
-
29144478503
-
Peripheral neuropathy: A persisting challenge in paclitaxel-based regimes
-
Mielke S, Sparreboom A, Mross K. Peripheral neuropathy: A persisting challenge in paclitaxel-based regimes. Eur J Cancer 2006;42:24-30.
-
(2006)
Eur J Cancer
, vol.42
, pp. 24-30
-
-
Mielke, S.1
Sparreboom, A.2
Mross, K.3
-
28
-
-
0028355959
-
Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings
-
Sahenk Z, Barohn R, New P, Mendell JR. Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch Neurol 1994;51: 726- 9.
-
(1994)
Arch Neurol
, vol.51
, pp. 726-729
-
-
Sahenk, Z.1
Barohn, R.2
New, P.3
Mendell, J.R.4
-
29
-
-
0028999006
-
Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol
-
Cavaletti G, Tredici G, Braga M, Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol 1995;133:64-72.
-
(1995)
Exp Neurol
, vol.133
, pp. 64-72
-
-
Cavaletti, G.1
Tredici, G.2
Braga, M.3
Tazzari, S.4
-
30
-
-
44149110392
-
C-jun is a negative regulator of myelination
-
Parkinson DB, Bhaskaran A, Arthur-Farraj P, Noon LA, Woodhoo A, Lloyd AC, et al. C-jun is a negative regulator of myelination. J Cell Biol 2008;181:625-37.
-
(2008)
J Cell Biol
, vol.181
, pp. 625-637
-
-
Parkinson, D.B.1
Bhaskaran, A.2
Arthur-Farraj, P.3
Noon, L.A.4
Woodhoo, A.5
Lloyd, A.C.6
-
31
-
-
61849088961
-
Role of mapks in platinum-induced neuronal apoptosis
-
Scuteri A, Galimberti A, Maggioni D, Ravasi M, Pasini S, Nicolini G, et al. Role of mapks in platinum-induced neuronal apoptosis. Neurotoxicology 2009;30:312-9.
-
(2009)
Neurotoxicology
, vol.30
, pp. 312-319
-
-
Scuteri, A.1
Galimberti, A.2
Maggioni, D.3
Ravasi, M.4
Pasini, S.5
Nicolini, G.6
-
32
-
-
34147198467
-
Synthetic lethal screen identification of chemosensitizer loci in cancer cells
-
Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007;446:815-9.
-
(2007)
Nature
, vol.446
, pp. 815-819
-
-
Whitehurst, A.W.1
Bodemann, B.O.2
Cardenas, J.3
Ferguson, D.4
Girard, L.5
Peyton, M.6
-
33
-
-
41149156857
-
Wnt-3a and dickkopf-1 stimulate neurite outgrowth in ewing tumor cells via a frizzled3- And c-jun n-terminal kinase-dependent mechanism
-
Endo Y, Beauchamp E,Woods D, TaylorWG,Toretsky JA, Uren A, et al. Wnt-3a and dickkopf-1 stimulate neurite outgrowth in ewing tumor cells via a frizzled3- and c-jun n-terminal kinase-dependent mechanism. Mol Cell Biol 2008;28:2368-79.
-
(2008)
Mol Cell Biol
, vol.28
, pp. 2368-2379
-
-
Endo, Y.1
Beauchamp, E.2
Woods, D.3
Taylor, W.G.4
Toretsky, J.A.5
Uren, A.6
-
34
-
-
0033910767
-
N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-lom
-
Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-lom. Am J Hum Genet 2000;67: 47 - 58.
-
(2000)
Am J Hum Genet
, vol.67
, pp. 47-58
-
-
Kalaydjieva, L.1
Gresham, D.2
Gooding, R.3
Heather, L.4
Baas, F.5
De Jonge, R.6
-
35
-
-
79959738646
-
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer
-
Bergmann TK, Green H, Brasch-Andersen C, Mirza MR, Herrstedt J, Holund B, et al. Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer. Eur J Clin Pharmacol 2011;67:693-700.
-
(2011)
Eur J Clin Pharmacol
, vol.67
, pp. 693-700
-
-
Bergmann, T.K.1
Green, H.2
Brasch-Andersen, C.3
Mirza, M.R.4
Herrstedt, J.5
Holund, B.6
-
36
-
-
79953052657
-
Polymorphisms in cytochromes p450 2c8 and 3a5 are associated with paclitaxel neurotoxicity
-
Leskela S, Jara C, Leandro-Garcia LJ, Martinez A, Garcia-Donas J, Hernando S, et al. Polymorphisms in cytochromes p450 2c8 and 3a5 are associated with paclitaxel neurotoxicity. Pharmacogenomics J 2011;11:121-9.
-
(2011)
Pharmacogenomics J
, vol.11
, pp. 121-129
-
-
Leskela, S.1
Jara, C.2
Leandro-Garcia, L.J.3
Martinez, A.4
Garcia-Donas, J.5
Hernando, S.6
-
37
-
-
35648997048
-
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: The scottish randomised trial in ovarian cancer
-
Marsh S, Paul J, King CR, Gifford G, McLeod HL, Brown R. Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: The scottish randomised trial in ovarian cancer. J Clin Oncol 2007;25:4528-35.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4528-4535
-
-
Marsh, S.1
Paul, J.2
King, C.R.3
Gifford, G.4
McLeod, H.L.5
Brown, R.6
-
38
-
-
33751044628
-
Association of abcb1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia
-
Sissung TM, Mross K, Steinberg SM, Behringer D, Figg WD, Sparreboom A, et al. Association of abcb1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia. Eur J Cancer 2006;42: 2893- 6.
-
(2006)
Eur J Cancer
, vol.42
, pp. 2893-2896
-
-
Sissung, T.M.1
Mross, K.2
Steinberg, S.M.3
Behringer, D.4
Figg, W.D.5
Sparreboom, A.6
-
39
-
-
78049528598
-
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: A prospective analysis of data from the hovon-65/gmmg-hd4 trial
-
Broyl A, Corthals SL, Jongen JL, van der Holt B, Kuiper R, de Knegt Y, et al. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the hovon-65/gmmg-hd4 trial. Lancet Oncol 2010;11:1057 -65.
-
(2010)
Lancet Oncol
, vol.11
, pp. 1057-1065
-
-
Broyl, A.1
Corthals, S.L.2
Jongen, J.L.3
Van Der Holt, B.4
Kuiper, R.5
De Knegt, Y.6
-
40
-
-
81255167970
-
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
-
Cavaletti G, Alberti P, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics. Lancet Oncol 2011;12:1151-61.
-
(2011)
Lancet Oncol
, vol.12
, pp. 1151-1161
-
-
Cavaletti, G.1
Alberti, P.2
Marmiroli, P.3
-
41
-
-
79951672140
-
Genetic variation associated with bortezomib-induced peripheral neuropathy
-
Favis R, Sun Y, van de Velde H, Broderick E, Levey L, Meyers M, et al. Genetic variation associated with bortezomib-induced peripheral neuropathy. Pharmacogenet Genom 2011;21:121-9.
-
(2011)
Pharmacogenet Genom
, vol.21
, pp. 121-129
-
-
Favis, R.1
Sun, Y.2
Van De Velde, H.3
Broderick, E.4
Levey, L.5
Meyers, M.6
-
42
-
-
79952322815
-
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma
-
Johnson DC, Corthals SL, Walker BA, Ross FM, Gregory WM, Dickens NJ, et al. Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma. J Clin Oncol 2011;29: 797-804.
-
(2011)
J Clin Oncol
, vol.29
, pp. 797-804
-
-
Johnson, D.C.1
Corthals, S.L.2
Walker, B.A.3
Ross, F.M.4
Gregory, W.M.5
Dickens, N.J.6
-
43
-
-
77956640698
-
Assessment of cancer-related neuropathy and neuropathic pain
-
Cleeland CS, Farrar JT, Hausheer FH. Assessment of cancer-related neuropathy and neuropathic pain. Oncologist 2010;15 Suppl 2:13-8.
-
(2010)
Oncologist
, vol.15
, Issue.SUPPL. 2
, pp. 13-18
-
-
Cleeland, C.S.1
Farrar, J.T.2
Hausheer, F.H.3
-
44
-
-
1542379860
-
Neurotoxicity of taxanes: Symptoms and quality of life assessment
-
Kuroi K, Shimozuma K. Neurotoxicity of taxanes: Symptoms and quality of life assessment. Breast Cancer 2004;11:92-9.
-
(2004)
Breast Cancer
, vol.11
, pp. 92-99
-
-
Kuroi, K.1
Shimozuma, K.2
-
45
-
-
0033946726
-
Grading of chemotherapy-induced peripheral neuropathy
-
Postma TJ, Heimans JJ. Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol 2000;11:509-13.
-
(2000)
Ann Oncol
, vol.11
, pp. 509-513
-
-
Postma, T.J.1
Heimans, J.J.2
-
46
-
-
84868480398
-
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-sas bc 02, a randomized clinical trial
-
May 15. [Epub ahead of print]
-
Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, et al. Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-sas bc 02, a randomized clinical trial. Support Care Cancer. 2012 May 15. [Epub ahead of print].
-
(2012)
Support Care Cancer
-
-
Shimozuma, K.1
Ohashi, Y.2
Takeuchi, A.3
Aranishi, T.4
Morita, S.5
Kuroi, K.6
-
47
-
-
84880917710
-
Genome-wide association studies in pharmacogenomics: Successes and lessons
-
2010 Jul 15. [Epub ahead of print]
-
Motsinger-Reif AA, Jorgenson E, Relling MV, Kroetz DL, Weinshilboum R, Cox NJ, et al. Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genom 2010. 2010 Jul 15. [Epub ahead of print].
-
(2010)
Pharmacogenet Genom
-
-
Motsinger-Reif, A.A.1
Jorgenson, E.2
Relling, M.V.3
Kroetz, D.L.4
Weinshilboum, R.5
Cox, N.J.6
|